ALDH1A1 and glioblastoma: We showed previously that, in human GBM, ALDH1 is involved in therapy resistance against the standard chemotherapeutic agent temozolomide by detoxifying toxic aldehydes resulting from oxidative stress and consequent activation of LPO, and that this process seems to be mediated at least in part by autophagy [5].